SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-21-057534
Filing Date
2021-04-29
Accepted
2021-04-29 16:02:14
Documents
14
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2114600d1_10ka.htm   iXBRL 10-K/A 286041
2 EXHIBIT 31.1 tm2114600d1_ex31-1.htm EX-31.1 3864
3 EXHIBIT 31.2 tm2114600d1_ex31-2.htm EX-31.2 3648
  Complete submission text file 0001104659-21-057534.txt   535660

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA casi-20201231.xsd EX-101.SCH 3187
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE casi-20201231_lab.xml EX-101.LAB 35162
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE casi-20201231_pre.xml EX-101.PRE 23093
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2114600d1_10ka_htm.xml XML 5367
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-20713 | Film No.: 21870350
SIC: 2836 Biological Products, (No Diagnostic Substances)